沪深市场个股详情

603259 药明康德

添加自选

43.67
-0.90-2.02%

休市中 04/30 15:00 (北京)

1280.99亿总市值13.66市盈率TTM

药明康德股票讨论区

登录发表评论

HappyGotLucky

6小时前

$药明康德(02359.HK)$ Nice. back to the game!

HappyGotLucky

04/29 10:43

$WUXI APPTEC (02359.HK)$ Some good news should be coming. Strong buyback by the company for the past few days.

70226489

04/25 10:42

$药明康德(02359.HK)$ 要起飞了🛫️

Peter YCS

04/16 11:35

$药明康德(02359.HK)$ 30块钱，跌到 30 在加仓……中共拉圾股，只会下跌📉，当着拉圾回收……

70226489

04/12 10:02

$药明康德(02359.HK)$ 这个股票只会跌么

赵发财

04/09 09:45

$药明康德(603259.SH)$ 🗑️💩🗑️

让子弹飞（SG)

03/28 09:45

$药明康德(02359.HK)$ 空方力量越来越小，股价修复即将到来

Spinee

03/27 11:26

JUST IN:

China's January to February industrial profit grew by 10.2% y/y to 0.914 trillion yuan.
NBS:

Revenue growth at industrial enterprises picked up markedly as market demand continued to recover and industrial output expanded rapidly, which created favorable conditions for their profits.

Some 29 out of China's 41 main industries saw profits rise in the first two months.
$阿里巴巴(BABA.US)$$阿里巴巴-SW(09988.HK)$$腾讯控股(00700.HK)$$小米集团-W(01810.HK)$$京东集团-SW(09618.HK)$$百度集团-SW(09888.HK)$$比亚迪股份(01211.HK)$$商汤-W(00020.HK)$$中国石化(600028.SH)$

Spinee

03/27 10:09

Wuxi Biologics Earnings Report: FY Net Income Misses Estimates Despite Revenue Surpassing Predictions

Wuxi Biologics has reported a full-year net income of 3.40 billion yuan, falling short of the estimated 3.58 billion yuan.

The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan.

Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan.

The gross margin for the c...

让子弹飞（SG)

03/27 10:02

$药明合联(02268.HK)$ 交银国际：维持药明合联(02268)“买入”评级目标价42港元$药明生物(02269.HK)$$药明康德(02359.HK)$

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

沪深

综合热度